InvestorsHub Logo
Followers 138
Posts 22903
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Friday, 08/29/2014 6:48:27 PM

Friday, August 29, 2014 6:48:27 PM

Post# of 2206
From DUKE

"...Dr Barry Mangum, Director of Clinical Pharmacology at Duke, who noted: “We remain vigilant in the quest for success. This therapy, if proven successful, will be life changing to those patients who desperately require eradication of HCV. We at Duke remain committed to support Benitec’s efforts to complete the first trial of this promising treatment.”..."

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News